The role of wild-type p53 in the differentiation of primary hemopoietic and muscle cells

被引:0
|
作者
Giuseppina Mazzaro
Gianluca Bossi
Sabrina Coen
Ada Sacchi
Silvia Soddu
机构
[1] Molecular Oncogenesis Laboratory,
[2] Regina Elena Cancer Institute,undefined
[3] C.R.S.,undefined
来源
Oncogene | 1999年 / 18卷
关键词
p53; differentiation; satellite cell; bone marrow; transformation;
D O I
暂无
中图分类号
学科分类号
摘要
Experiments previously performed on 32D and C2C12 cell lines indicated that wild type p53 (wtp53) protein has a role in granulocyte and myotube differentiation. Since these are immortal cells, we asked whether the inhibition of differentiation induced by the expression of dominant-negative p53 (dnp53) proteins was dependent on the immortalization-determined microenvironment. Thus, we evaluated the effects produced by interfering with the endogenous p53 gene in murine primary hemopoietic and muscle cells. Expression of dnp53 protein reduced the differentiation of bone marrow cells into granulocytes and macrophages. Moreover, p53 activation was measurable during the differentiation process of primary myoblasts, while interference with this activation led to a consistent slow down of terminal differentiation. Since the impairment of the differentiation was not accompanied by alterations in the cell cycle withdrawal and in the rate of apoptosis which are coupled with these types of differentiation, the data here reported support a specific role for p53 in the differentiation process. However, the difference in the intensity of inhibition between immortal and primary cells, i.e., complete versus slow down, respectively, suggests that the immortalization process might render the cells more sensitive to the loss of wtp53 activity for the differentiation process.
引用
收藏
页码:5831 / 5835
页数:4
相关论文
共 50 条
  • [1] The role of wild-type p53 in the differentiation of primary hemopoietic and muscle cells
    Mazzaro, G
    Bossi, G
    Coen, S
    Sacchi, A
    Soddu, S
    ONCOGENE, 1999, 18 (42) : 5831 - 5835
  • [2] DOES WILD-TYPE P53 PLAY A ROLE IN NORMAL-CELL DIFFERENTIATION
    ROTTER, V
    ALONIGRINSTEIN, R
    SCHWARTZ, D
    ELKIND, NB
    SIMONS, A
    WOLKOWICZ, R
    LAVIGNE, M
    BESERMAN, P
    KAPON, A
    GOLDFINGER, N
    SEMINARS IN CANCER BIOLOGY, 1994, 5 (03) : 229 - 236
  • [3] Role of p53 in the inhibition of proliferation of gastric cancer cells expressing wild-type or mutated p53
    Ji, Wansheng
    Ma, Jingrong
    Zhang, Hongmei
    Zhong, Hua
    Li, Lei
    Ding, Na
    Jiao, Jianxin
    Gao, Zhixing
    MOLECULAR MEDICINE REPORTS, 2015, 12 (01) : 691 - 695
  • [4] Wild-type p53 overexpression: What role in tumorigenesis?
    Wolf, JK
    Wharton, JT
    GYNECOLOGIC ONCOLOGY, 1996, 60 (03) : 337 - 338
  • [5] COTRANSLATION OF ACTIVATED MUTANT P53 WITH WILD-TYPE DRIVES THE WILD-TYPE P53 PROTEIN INTO THE MUTANT CONFORMATION
    MILNER, J
    MEDCALF, EA
    CELL, 1991, 65 (05) : 765 - 774
  • [6] Activities of wild-type and mutant p53
    Vousden, Karen H.
    CANCER RESEARCH, 2013, 73
  • [7] Flavonoids activate wild-type p53
    Plaumann, B
    Fritsche, M
    Rimpler, H
    Brandner, G
    Hess, RD
    ONCOGENE, 1996, 13 (08) : 1605 - 1614
  • [8] ACCUMULATION OF WILD-TYPE P53 IN MENINGIOMAS
    ELLISON, DW
    LUNEC, J
    GALLAGHER, PJ
    STEART, PV
    JAROS, E
    GATTER, KC
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1995, 21 (02) : 136 - 142
  • [9] Effects of adenoviral wild-type p53 gene transfer in p53 -mutated lymphoma cells
    Peter Buttgereit
    Frank Schakowski
    Angela Märten
    Karsten Brand
    Sabine Renoth
    Carsten Ziske
    Björn Schöttker
    Oliver Ebert
    Roland Schroers
    Ingo GH Schmidt-Wolf
    Cancer Gene Therapy, 2001, 8 : 430 - 439
  • [10] Contribution of the p53 pathway in cancers that carry wild-type p53
    Ohki, Rieko
    CANCER SCIENCE, 2022, 113 : 1232 - 1232